INTRODUCTION
A wide range of benign, premalignant and malignant lesions may occur in the vulvar region. The most common symptom of both benign and malignant vulvar lesions is vulval itching. 1 The spectrum of vulvar lesions is large, ranging from dystrophy to a frank carcinoma. Vulvar dystrophy refers to a clinically related group of disorders of epithelial growth that usually present as white lesions and hence the older terminology of leukoplakia. Vulvar carcinoma is encountered most frequently in postmenopausal women. 2 The clinician is often faced with the challenge to make a distinction between normal variants, benign entities and a potentially serious pathology. The general approach for evaluation of vulval lesions includes a pertinent clinical history, physical examination and diagnostic studies. 3 In lesions clinically suspicious for malignancy (asymmetry, border irregularity, color variation, rapid change, bleeding, non-healing) one or more vulvar biopsies are recommended. The biopsy should be strongly considered in cases where a diagnosis cannot be made confidently on visual inspection and by non invasive methods or if the lesion does not resolve after standard therapy. It is extremely beneficial to establish the diagnosis by biopsy early, as the clinical features may change over time. The present study is undertaken to describe the histopathological findings in vulvar biopsies and further categorize the spectrum of vulvar lesions.
METHODS
The present retrospective study compiles the data from archival records over a period of eight years from January 2005 to December 2012. The clinical data including the age, patients' complaints, findings on general physical examination and local examination along with the clinical possibilities were noted from the file records.
A total of 171 biopsies and 2 vulvectomy specimens received from 170 patients were reviewed. In one patient a repeat biopsy was received. In 2 cases, biopsy diagnosis was followed by vulvectomy. Routine hematoxylin and eosin staining was done on sections from paraffin embedded and formalin fixed tissues. Serial sections and special stains were done wherever required.
RESULTS

Clinical features
The age of the women ranged from 6 to 80 years (mean 38.2, 95% confidence interval for mean, 31.8 to 44.6) with the maximum number of patients between 31 to 40 years of age. Most common clinical presentation was itching and white plaque on the vulva (85 cases; 50%); other presentations being swelling, nodularity, ulcer and discharge. The commonest site of vulval lesions was labia majora (87 cases, 51.18 %) followed by labia minora (73 cases, 42.94%). In 6 cases the biopsies were taken from multiple sites including clitoris, fourchette, labia majora and labia minora. Two biopsies were from perineal area and one from mons pubis. In one case the site of biopsy was episiotomy scar.
Pathological findings
In 170 women who underwent vulvar biopsy, a spectrum of lesions (benign and malignant, neoplastic and nonneoplastic) was noted as shown in Table 1 . Among the neoplastic benign lesions, the most common tumor was fibroepithelial polyp in 12 cases (52.17%) followed by three cases (13.04%) each of hidradenoma papilliferum and aggressive angiomyxoma. One case each of apocrine hidrocystoma, angiokeratoma ( Figure  2 ), cavernous hemangioma, leiomyoma and neurofibroma ( Figure 3 ) was reported. Microscopically, fibroepithelial polyps showed lesion with connective tissue stalk containing blood vessels and loose collagen covered by keratinized stratified squamous epithelium. Microscopically, hidradenoma papilliferum showed a well circumscribed lesion composed of a cystic space containing papillary structures having delicate fibrovascular branching stalks. There were numerous tubules and acini lined by inner columnar epithelium with an outer compressed layer of myoepithelial cells. The biopsies in three cases of aggressive angiomyxoma revealed an infiltrative, poorly circumscribed tumor composed of bland spindle to stellate cells along with blood vessels of varying caliber, embedded in a hypocellular myxoid stroma. There was no evidence of atypia or significant mitoses in these cases. The background stroma stained positively with alcian blue. Two cases of condyloma acuminatum were diagnosed. The biopsy revealed hyperkeratosis, acanthosis and papillomatosis of the stratified squamous epithelium with keratinocytes having a distinct vacuolated cytoplasm containing a pyknotic nucleus surrounded by a halo (koilocyte). Six cases (22.22%) were diagnosed as vulvar intraepithelial neoplasm (VIN) where the biopsies revealed a full thickness squamous dysplasia with no invasion of the underlying basement membrane (Figure 4 & 5) . Squamous cell carcinoma was seen in 17 (62.96%) cases and one case each of microinvasive squamous cell carcinoma and verrucous carcinoma ( Figure 6 ) was diagnosed. Twenty six cases (15.30%) in which a definitive histologic diagnosis could not be reached were rendered as inconclusive on histopathologic biopsy for various reasons such as non-representative or inadequate biopsy. One such descriptive biopsy was followed by a repeat biopsy based on high clinical suspicion of carcinoma. The repeat biopsy revealed squamous cell carcinoma (SCC). Two biopsies where diagnosis of SCC was given were followed by vulvectomy specimens.
DISCUSSION
Patients with vulval disorders are well managed by a multidisciplinary approach with the expertise of both gynecologist and dermatologist. 4 Dermatitis affecting vulva may occur at any age and is not uncommon. The development of cancer subsequent to clinical presentation of dermatosis is a well known phenomenon. The opinion of a histopathologist with a keen interest in this arena is of paramount importance. 5 Most of the authors have emphasized the role of vulvar skin biopsy with subsequent histologic analysis by a dermatopathologist in diagnosing vulvar diseases. 6, 7 A biopsy is mandatory for assessment of invasion in neoplastic vulvar epithelial lesions. For an accurate diagnosis, judicious selection of biopsy sample locations is important. 8 For palpable tumors, biopsy should contain the tumor mass with surrounding normal skin to comment on the extent of invasion. In patients with indistinct tumor boundaries, topical agents like diluted acetic acid may be used for identification of acetowhite/suspicious areas. Toluidine blue may be used for identifying dysplastic tissue which can be biopsied. 8, 9 There was a wide age range of 6 to 80 years (mean 38.2±6.4) in the present study. A significant number of women were post menopausal (38%) which is usually the case. 9 One hundred forty four (84.70%) women had disease of the skin or vulvar mucosa identified on histopathology and 26 (15.30%) of women had non-specific findings. This is low but it can be as high as 39%. 6 The most common dermatologic conditions encountered in our study were lichen sclerosus, spongiotic dermatitides, atopic dermatitis and lichen planus as reported in other studies. 5, 6, 10 Lichen sclerosus was seen in 32% patients, which is higher than observed in some studies because women in our country do not admit to symptomatology in early stage. 10 Biopsies in cases of lichen sclerosus are useful for confirmation of clinical diagnosis and to exclude early invasive malignancy.
Primary lesions are diagnosed on histolopathology using nomenclature given by The International Society for the Study of Vulvar Diseases which has emphasized that there is no evidence that the VIN 1-3 morphologic spectrum reflects a biologic continuum. 11, 12 The Vulvar Intraepithelial Neoplasia (VIN) is divided into 3 grades depending on the extent of thickness of epithelium involved in neoplastic process. Extension of the neoplastic cells into the stroma is invasive vulvar cancer. VIN 3 or full thickness dysplasia may be warty, basaloid and differentiated. The distinction between VIN lesions and early invasive SCC can only be done on histopathologic examination, hence necessitating a biopsy of all suspicious vulvar lesions. Furthermore, the erosive forms of VIN might indicate start of tumor invasion and hence a mandatory biopsy. 13 In our study VIN was seen in six cases while early invasive SCC was reported in a single case.
For appropriate intervention and effective management with decreased morbidity and mortality, an early definitive diagnosis of vulvar cancer is necessary. Lichen sclerosus is commonly seen associated with differentiated-type VIN, which may be misdiagnosed as lichen sclerosus or other benign dermatosis. The number of carcinoma cases associated with differentiated-type VIN outnumbers those with lichen sclerosus.
14 Lichen sclerosus with dyskeratosis and/or parakeratosis, hyperplasia and basal cellular atypia on histopathologic examination warrants a close follow-up due to increased risk for malignant progression. The estimated risk is around 5%. 15 Follow-up does not prevent neoplastic change in women with lichen sclerosus but helps in early detection of any malignant transformation. 16 Squamous cell carcinoma comprises about 90% of all vulval cancers, the others being melanoma, Paget's disease, Bartholin's gland tumour, adenocarcinoma and basal cell carcinoma. 15, 17 The most common type of vulvar squamous carcinoma is keratinizing type associated with differentiated VIN or a vulvar dystrophy. [18] [19] [20] Verrucous carcinoma is seen in <1% cases. 15 In our study vulvar squamous cell carcinoma was seen in 17 cases while verrucous carcinoma was reported in a single case. In one study out of 55 vulvar biopsies SCC was seen in six of the cases. 2 Two pathways seem to play a role in development of vulvar cancer. The first one leads mainly to nonkeratinizing, basaloid and/or warty carcinomas usually affecting young females. Infection with high-risk human papilloma viruses like HPV 16 and 18 is involved. These cancers are associated with warty and/or basaloid VIN, also known as classic/bowenoid VIN. As per the latest terminology, HPV-positive VIN lesions are called VIN, usual type. The prognosis is better in vulvar squamous cell carcinomas which are HPV-positive. The other pathway leads to mostly differentiated keratinizing squamous cell carcinoma developing in a background of nonneoplastic epithelial disorders like lichen sclerosus. These tumors are rarely associated with high-risk HPV and affect older females. The precursor form is called simplex/well differentiated VIN often difficult to distinguish from benign vulvar lesions like lichen sclerosus. 11, 21 The task of making a distinction between normal variants, benign entities and potentially serious vulvar pathology is challenging. Early recognition of vulvar lesions and a prompt biopsy diagnosis with subsequent histologic analysis by a dermatopathologist is advocated. The term leukoplakia is imprecise and confusing and should be replaced by precise histological description. Considering the psychosexual impact of vulvar neoplasia and given the association of dermatosis and vulvar squamous cell carcinoma, lesions with suspicious changes warrant a biopsy diagnosis.
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